Fund Name | Location |
Altran | France, Ile-de-France, Neuilly-sur-seine |
BankDhofar | Muscat, Muscat, Oman |
Bartlit Beck Herman Palenchar & Scott | Chicago, Illinois, United States |
Cambrian Biopharma | New York, New York, United States |
Capimont | Canada, Montréal, Quebec |
CresVentures | Lahore, Pakistan, Punjab |
DIC | Japan, Shizuoka, Shizuoka Prefecture |
EVC Thirty One Holdings | - |
Exome Asset Management | New York, New York, United States |
FRB Capital Group | - |
Kinara | Indonesia, Jakarta, Jakarta Raya |
Nanjing Huanli Shiye | China, Jiangsu, Nanjing |
Nanyang Ventures | Australia, New South Wales, Sydney |
Neev Fund | India, Maharashtra, Mumbai |
PBM Capital Group | Charlottesville, United States, Virginia |
Potent Assets | China, Hong Kong, Hong Kong Island |
Rite Ventures | Stockholm, Stockholm County, Sweden |
Rosebud Fund | - |
Sony Startup Acceleration Program | Lund, Skane Lan, Sweden |
Swiss Investors Corporation | China, Hong Kong, Hong Kong Island |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.